WallStSmart
ABEO

Abeona Therapeutics Inc

NASDAQ: ABEO · HEALTHCARE · BIOTECHNOLOGY

$5.34
-0.37% today

Updated 2026-04-29

Market cap
$303.75M
P/E ratio
5.29
P/S ratio
52.19x
EPS (TTM)
$1.01
Dividend yield
52W range
$4 – $8
Volume
1.2M

Abeona Therapeutics Inc (ABEO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-1.96M$4.84M$-6.56M$-2.25M$-6.86M$-7.61M$-3.96M$1000.00$-1.61M$-10.42M$-13.01M$-22.93M$-39.11M$-62.82M$-35.02M$-65.67M$-43.48M$-37.01M$-56.02M$-76.33M
Capital expenditures$3000.00$18000.00$93000.00$2000.00$7000.00$40000.00$13000.00$2000.00$308000.00$308000.00$519000.00$860000.00$19.49M$6.51M$1.34M$4.15M$130000.00$331000.00$2.45M$7.97M
Depreciation
Stock-based comp$77.00M$811000.00$1.01M$1.07M$390000.00$439000.00$1.30M$4.37M$4.83M$5.92M$8.87M$8.24M$8.19M$8.92M$3.05M$4.77M$6.63M$10.78M
Free cash flow$-1.96M$4.83M$-6.65M$-2.25M$-6.87M$-7.65M$-3.97M$-1000.00$-1.92M$-10.73M$-13.53M$-23.80M$-58.60M$-69.33M$-36.35M$-69.82M$-43.61M$-37.34M$-58.46M$-84.30M
Investing cash flow
Financing cash flow
Dividends paid$19.00M$82.00M$168.00M$271.00M$319.00M$2.90M$11.58B$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$28000.00$11.10M$28.62M$29.00M$68.61M$-118.72M$111.06M$-116.80M